Earnings History Data for Aprea Therapeutics, Inc. (APRE) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Aprea Therapeutics, Inc.

Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Aprea Therapeutics Inc. is based in Boston, Massachusetts.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
12-08-2021 AH APRE Aprea Therapeutics, Inc. 88.00 -0.48 -0.47 0.00 Aprea Therapeutics EPS beats by $0.02
[8/12/2021 5:03 PM]
3.65 -0.39 
(-9.65%)
3.74 -0.30 
(-7.43%)
3.38 - 31.45 1,208,658 580,000 94,843
06-05-2021 AH APRE Aprea Therapeutics, Inc. 92.00 -0.46 -0.52 0.00 Aprea Therapeutics EPS beats by $0.11
[5/6/2021 5:23 PM]
4.28 0.02 
(0.47%)
4.20 -0.06 
(-1.41%)
4.13 - 41.12 381,783 330,000 8,383
16-03-2021 AH APRE Aprea Therapeutics, Inc. 126.00 -0.73 -0.63 0.00 Aprea Therapeutics EPS misses by $0.10
[3/16/2021 4:51 PM]
5.91 -0.24 
(-3.90%)
5.69 -0.46 
(-7.48%)
4.66 - 41.12 935,068 729,554 35,321